Obesity
Conditions
Interventions
- Dairy group: 11 overweight/obese, female, low-calcium consumers (<800mg/day) received daily during 45 consecutive days breakfasts containing 700mg/day of calcium from skim milk, plus calorie-restric
- Supplemental group: 11 overweight/obese, female, low-calcium consumers (<800mg/day) received daily during 45 consecutive days breakfasts containing 700mg/day of calcium from the supplement calcium c
- Control group: 11 overweight/obese, female, low-calcium consumers (<800mg/day) received daily during 45 consecutive days placebo breakfasts (without any calcium source) calcium source (placebo) plus
Dietary supplement
SP6.051.227
Sponsors
Universidade Federal de Viçosa - UFV
Fundação do Amparo à Pesquisa do Estado de Minas Gerais - FAPEMIG
Eligibility
Sex/Gender
Female
Age
19 Years to 40 Years
Inclusion criteria
Inclusion criteria: Healthy overweight or obese women; calcium intake less than 800 mg/day; physical activity level of mild to moderate; aged between 19 and 40 years; non smokers; restriction and disinhibition level less than 14.
Exclusion criteria
Exclusion criteria: Use of calcium or vitamin D supplements or any medication that affects the metabolism of calcium; medications or herbs for weight reduction; adoption of diets for weight reduction; use of drugs for estrogen replacement; weight gain or loss more tran 3kg in the last three months; recent changes in physical activity level; aversion or intolerance to foods used in the study; consumption of alcohol higher than 2 servings a day; presence of eating disorders, endocrine pathology, renal disfunction, hepatic disease or malabsorption syndrome; caffeine intake more than 350mg/day; pregnance; lactance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total body fat loss more than 3.7% evaluated by dual-energy X-ray absorptiometry, after 45 days of intervention.;Average body fat loss of 4.97 % evaluated by dual-energy X-ray absorptiometry, after 45 days of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increased of at least 10% in the diet-induced energy expenditure, fat oxidation and total energy metabolism evaluated by indirect calorimetry; reduction of at least 5pg/dL of blood PTH measured by electrochemiluminescence method. ;Unexpected significant reduction of approximately 0.6mg/dL in uric acid blood levels by enzumatic colorimetric test in dairy and supplement groups compared to the control group. Other expected secondary outcomes had no significant differences between groups. | — |
Countries
Brazil
Contacts
Public ContactFlávia Cândido
Universidade Federal de Viçosa - UFV
Outcome results
None listed